Science & Technology
A Novel Platelet-Inspired Nanotechnology to Restore Hemostasis in Patients on Antiplatelet Agents
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44HL180258-01
Award Ceiling
$945K
Award Floor
$945K
Close Date
Jun 30, 2027
472 days leftTotal Funding
$945K
Expected Awards
1
Posted Date
Jul 15, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R44HL180258-01
Description
SBIR Phase Phase II award: "A Novel Platelet-Inspired Nanotechnology to Restore Hemostasis in Patients on Antiplatelet Agents" awarded to Haima Therapeutics LLC in Cleveland, Ohio. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $944,676. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.